Home The Action Management Committee Péter Ferdinandy (HU)


Prof. Péter Ferdinandy, MD, PhD, MBA

Pharmahungary Group
Hajnóczy u 6,
H-6722 Szeged, Hungary
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Cardiovascular Research Groups,
University of Szeged, Szeged,
and Semmelweis University, Budapest,

Research Interests

  • direct effect of metabolic diseases (hyperlipidemia and diabetes) on cardioprotection
  • NO-cGMP-PKG signaling, and peroxynitrie-matrix metalloproteinase signalling
  • cardioprotection by new mechanisms: biglycan, microRNA-s
  • in vivo animal models for cardioprotection

Selected Recent Publications

  • Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskas LG, Csonka C, Csont T, Ferdinandy P. Role of iNOS and peroxynitrite - matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats. Am J Physiol Heart Circ Physiol, 299: H512-518, 2010
  • Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Res Cardiol. 105(5):643-50, 2010
  • Csont T, Görbe A, Bereczki E, Szunyog A, Aypar E, Tóth ME, Varga ZV, Csonka C, Fülöp F, Sántha M, Ferdinandy P. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J Mol Cell Cardiol, 48:649-52, 2010
  • Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, Csont T, Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol. 297: H1729-35, 2009




POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.